| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $819K | +95.0% |
| Cost of Revenue | $63K | +50.0% |
| Gross Profit | $756K | +100.0% |
| R&D Expense | $862K | +216.9% |
| SG&A Expense | $12.1M | +6.4% |
| Operating Income | -$21.1M | -88.1% |
| Pre-tax Income | -$19.5M | -44.5% |
| Income Tax | -$1.8M | -157.6% |
| Net Income | -$17.2M | -3.2% |
| EPS (Basic) | -$15.90 | -138.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $88K | -96.9% |
| Accounts Receivable | $155K | +121.4% |
| Inventory | $86K | +160.6% |
| Current Assets | $390K | -88.2% |
| Total Assets | $15.9M | -42.9% |
| Current Liabilities | $3.9M | +87.4% |
| Long-term Debt | $3.1M | — |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.3M | +10.5% |
| Capital Expenditures | $17K | -74.6% |
| Investing Cash Flow | $167K | +349.3% |
| Financing Cash Flow | $5.3M | -38.2% |
| Free Cash Flow | -$8.3M | +11.0% |
| $9.2M |
| -42.5% |
| Stockholders' Equity | $7.1M | -40.0% |